EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Regulated cell death in ovarian cancer: molecular mechanisms and therapeutic targets

Yu Liu, Zhixing Geng, Baofu Jia, Xinxin Wang, Hongge Ju, Junxia Bao, Xiaoqin Liao, Xiaopeng Deng, Ye Guo, Fu Lin

Frontiers in Cell and Developmental Biology · 07.08.2026 · 14

DOI: 10.3389/fcell.2026.1910706 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 07.08.2026. Verfasst von Yu Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Baotou Medical College, Baotou, China. Die Arbeit nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Inner Mongolia Autonomous Region, Baotou Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) poses a significant threat to women’s health due to its high malignancy and poor prognosis, with limited efficacy of existing targeted therapies. In recent years, the elucidation of molecular mechanisms underlying regulated cell death (RCD) has substantially broadened our understanding of OC pathogenesis and therapeutic resistance, rendering the modulation of RCD pathways by small-molecule compounds a highly promising therapeutic strategy. This review systematically outlines the mechanistic underpinnings of multiple major RCD subtypes in OC, with a focused summary of advances in innovative small-molecule compounds targeting these pathways; discusses nanodelivery platforms for RCD modulation, predictive biomarkers for patient stratification, and the current landscape of clinical trials targeting RCD in OC; and finally analyzes the opportunities and challenges in clinical translation within this field, aiming to provide novel insights and directions for precision therapy in OC.

Schlagwörter

Stichwörter der Autor:innen

cancer therapymechanismsovarian cancerregulated cell deathsmall-molecule compounds

Autor:innen und Institutionen

  • School of Pharmacy, Baotou Medical College, Baotou, China.
  • School of Basic Medicine and Forensic Science, Baotou Medical College, Baotou, China.

Förderung

  • Natural Science Foundation of Inner Mongolia Autonomous Region
  • Baotou Medical College

Zitieren

APA

Liu, Y., Geng, Z., Jia, B., Wang, X., Ju, H., Bao, J., Liao, X., Deng, X., Guo, Y., & Lin, F. (2026). Regulated cell death in ovarian cancer: molecular mechanisms and therapeutic targets. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1910706

Vancouver

Liu Y, Geng Z, Jia B, Wang X, Ju H, Bao J, et al. Regulated cell death in ovarian cancer: molecular mechanisms and therapeutic targets. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1910706

BibTeX
@article{Liu2026,
  author = {Liu, Yu and Geng, Zhixing and Jia, Baofu and Wang, Xinxin and Ju, Hongge and Bao, Junxia and Liao, Xiaoqin and Deng, Xiaopeng and Guo, Ye and Lin, Fu},
  title = {Regulated cell death in ovarian cancer: molecular mechanisms and therapeutic targets},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1910706}
}
Kostenlos starten →